PEL Enterprises should publish a guidance (not sure when but pretty soon) on what % of acquisition cost of earlier PEL can be attributed to PEL finance and remaining to Pharma.
e.g. Just an example below, so you will need to wait till they release this guidance value/%. PEL might say 52% value is spun into finance business and remaining 48% in PPharma.
In this case If,
- PEL is acquired before demerger at Rs. X (i.e. say Rs. 2000)
Then, based on guidance, - PEL Finance acquisition cost for calculating Capital Gain after demerger is Rs. 0.52 multipled X (i.e. 0.52×2000 = Rs. 1040)
- PPharma acquisition cost for calculating Capital Gain will be Rs. 0.48 multipled X (i.e. 0.48×2000 = Rs. 960), since we get 4 shares per demerger ratio, 1 share acquisition cost for calculating Capital Gain of PPharma will be 0.48/4 multipled by X (i.e. 0.12×2000 = Rs. 240).
Hope this helps. We need to wait for PEL guidance on % split to calcualte the respective acquisition costs.
| Subscribe To Our Free Newsletter |
